Davis is an associate professor of medicine and urology and vice president for Cancer Care Network and Strategy at Vanderbilt University Medical Center, Nashville, Tennessee.
BCG-unresponsive NMIBC: Current evidence and options
Multiple investigational agents have been developed and are being studied.
FDA news recap in urology for Q2 2025
da Vinci 5 Surgical System approved in Europe
RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice
RX Review: TURBT vs chemoablation for low-grade, intermediate-risk NMIBC